Condition 1: Neutropenia. Condition 2: Fever. Agranulocytosis Fever, unspecified
Conditions
Interventions
Intervention 1: Intervention:
Administration of Oral tablets of Ciprofloxacin 500 mg/bid after diagnosis of neutropenia until occurrence of fever or resolution of neutropenia. Intervention 2: Control:
Prevention
Intervention:
Administration of Oral tablets of Ciprofloxacin 500 mg/bid after diagnosis of neutropenia until occurrence of fever or resolution of neutropenia
Control: Administration of Oral tablets of Placebo /bid after diagnosis of neutropenia until occurrence of fever or resolution of neutropenia
Sponsors
AJA University of Medical Sciences
Eligibility
Sex/Gender
All
Age
17 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Absolute neutrophil count < 500 or less 1000 with predicted fall to below 500 in 48-72 hours; History of Malignancy. Exclusion criteria: Fever or Any sign of clinical or microbiological infection; Any history of antibiotic consumption lately before admission.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: After intervention. Method of measurement: Body core temperature by Thermometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bacterial Infection. Timepoint: After intervention. Method of measurement: Blood, urine or sputum culture. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Asgari
Infectious Diseases Research Center, AJA University of Medical Sciences
Outcome results
None listed